Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 18, 2022 - Issue 1
Submit an article Journal homepage
4,771
Views
5
CrossRef citations to date
0
Altmetric
Coronavirus – Case Report

Detection of anti-NMDA receptor antibodies following BBIBP-CorV COVID-19 vaccination in a rituximab-treated person with multiple sclerosis presenting with manifestations of an acute relapse

Masoud Etemadifara Department of Neurosurgery, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran;b Alzahra Research Institute, Alzahra University Hospital, Isfahan University of Medical Sciences, Isfahan, IranView further author information
,
Hosein Nourib Alzahra Research Institute, Alzahra University Hospital, Isfahan University of Medical Sciences, Isfahan, Iran;c Network of Immunity in Infection, Malignancy, and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Isfahan, IranORCID Iconhttps://orcid.org/0000-0003-1808-0443View further author information
ORCID Icon,
Mehri Salarid Functional Neurosurgery Research Center, Shohada Tajrish Comprehensive Neurosurgical Center of Excellence, Shahid Beheshti University of Medical Sciences, Tehran, IranIranORCID Iconhttps://orcid.org/0000-0001-7102-821XView further author information
ORCID Icon &
Nahad Sedaghatb Alzahra Research Institute, Alzahra University Hospital, Isfahan University of Medical Sciences, Isfahan, Iran;c Network of Immunity in Infection, Malignancy, and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Isfahan, IranCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-2796-6791View further author information
ORCID Icon
Article: 2033540 | Received 15 Dec 2021, Accepted 21 Jan 2022, Published online: 03 Mar 2022

References

  • Al Kaabi N, Zhang Y, Xia S, Yang Y, Al Qahtani MM, Abdulrazzaq N, Al Nusair M, Hassany M, Jawad JS, Abdalla J, et al. Effect of 2 inactivated SARS-CoV-2 vaccines on symptomatic COVID-19 infection in adults: a randomized clinical trial. JAMA. 2021;326(1):35–4. doi:10.1001/jama.2021.8565.
  • Etemadifar M, Aghababaei A, Nouri H, Kargaran PK, Mohammadi S, Salari M. Autoimmune encephalitis: the first observational study from Iran. Neurol Sci. 2021. doi:10.1007/s10072-021-05400-1.
  • Wang H. Anti-NMDA receptor encephalitis and vaccination. Int J Mol Sci 18 1 . 2017;193.
  • Álvarez Bravo G, Ramió ITL. Anti-NMDA receptor encephalitis secondary to SARS-CoV-2 infection. Neurologia (Engl Ed). 2020;35:699–700. doi:10.1016/j.nrl.2020.07.013.
  • Burr T, Barton C, Doll E, Lakhotia A, Sweeney M. N-Methyl-d-Aspartate receptor encephalitis associated with COVID-19 infection in a toddler. Pediatr Neurol. 2021;114:75–76. doi:10.1016/j.pediatrneurol.2020.10.002.
  • Hou R, Wu J, He D, Yan Y, Li L. Anti-N-methyl-D-aspartate receptor encephalitis associated with reactivated Epstein-Barr virus infection in pediatric patients: three case reports. Medicine (Baltimore). 2019;98:e15726. doi:10.1097/MD.0000000000015726.
  • Sormani MP, Schiavetti I, Landi D, Carmisciano L, De Rossi N, Cordioli C, Moiola L, Radaelli M, Immovilli P, Capobianco M, et al. SARS-CoV-2 serology after COVID-19 in multiple sclerosis: an international cohort study. Multiple Sclerosis J. 2021;13524585211035318. doi:10.1177/13524585211035318.
  • Etemadifar M, Sedaghat N, Nouri H, Lotfi N, Chitsaz A, Khorvash R, Zolfaghari H, Ghasemi Movaghar A, Pourabbas M, Salari M, et al. SARS-CoV-2 serology among people with multiple sclerosis on disease-modifying therapies after BBIBP-CorV (Sinopharm) inactivated virus vaccination: same story, different vaccine. Mult Scler Relat Disord. 2021;103417. doi:10.1016/j.msard.2021.103417.
  • Etemadifar M, Nouri H, Salari M, Sedaghat N. Successful seroconversion following mild COVID-19 contraction in a double-vaccinated B-cell-depleted person with multiple sclerosis: a hint towards booster efficacy? Neuroimmunol Rep. 2021;1:100047. doi:10.1016/j.nerep.2021.100047.
  • Etemadifar M, Abhari AP, Nouri H, Akhavan Sigari A, Piran Daliyeh SM, Maracy MR, Salari M, Maleki S, Sedaghat N. Self-reported safety of the BBIBP-CorV (Sinopharm) COVID-19 vaccine among Iranian people with multiple sclerosis. medRxiv. 2021;2021.
  • Ali Sahraian M, Ghadiri F, Azimi A, Naser Moghadasi A. Adverse events reported by Iranian patients with multiple sclerosis after the first dose of Sinopharm BBIBP-CorV. Vaccine. 2021;39:6347–50. doi:10.1016/j.vaccine.2021.09.030.
  • Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011;10:63–74. doi:10.1016/S1474-4422(10)70253-2.
  • Hofmann C, Baur MO, Schroten H. Anti-NMDA receptor encephalitis after TdaP-IPV booster vaccination: cause or coincidence? J Neurol. 2011;258:500–01. doi:10.1007/s00415-010-5757-3.
  • Coeckelbergh E, Reynders T. Anti-NMDA receptor encephalitis after yellow fever vaccination: a case report. Acta Neurol Belg. 2021. doi:10.1007/s13760-021-01673-7.
  • Zuhorn F, Graf T, Klingebiel R, Schäbitz WR, Rogalewski A. Postvaccinal Encephalitis after ChAdOx1 nCov-19. Ann Neurol. 2021;90(3):506–11. doi:10.1002/ana.26182.
  • Torrealba-Acosta G, Martin JC, Huttenbach Y, Garcia CR, Sohail MR, Agarwal SK, Wasko C, Bershad EM, and Hirzallah MI. Acute encephalitis, myoclonus and sweet syndrome after mRNA-1273 vaccine. BMJ Case Rep 14 7 . 2021;e243173.
  • Vogrig A, Janes F, Gigli GL, Curcio F, Negro ID, D’Agostini S, Fabris M, Valente M. Acute disseminated encephalomyelitis after SARS-CoV-2 vaccination. Clin Neurol Neurosurg. 2021;208:106839. doi:10.1016/j.clineuro.2021.106839.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.